The reductive conversion of the carcinogen chromium (VI) and its role in the formation of DNA lesions

Annals of Clinical and Laboratory Science

Volumn 26, Issue 2, 1996, Pages 160-175

  Kortenkamp, Andreas ^a   Casadevall, Montse ^a   Da Cruz Fresco, Paula ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CHROMIUM; GLUTATHIONE TRANSFERASE;

ARTICLE; CARCINOGENICITY; DNA DAMAGE; DNA STRAND BREAKAGE; DNA STRUCTURE; GENE MUTATION; PRIORITY JOURNAL;

ANIMALS; ASCORBIC ACID; BOROHYDRIDES; CARCINOGENS; CATALASE; CATTLE; CHROMIUM; DNA DAMAGE; DNA, SINGLE-STRANDED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUTATHIONE; MALONDIALDEHYDE; MUTATION; OXIDATION-REDUCTION; PLASMIDS; TIME FACTORS;

EID: 0029877920     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Newman D. A case of adeno-carcinoma of the left inferior turbinated body, and the perforation of the nasal septum, in the person of a worker in chrome pigments. Glasgow Med J 1890;33:469-70.
2. IARC. Monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol 49, chromium, nickel and welding. International Agency on the Research of Cancer, Lyon, 1990.
3. Stern R. Chromium compounds. Production and occupational exposure. In: Langard, S, editor. Biological and environmental aspects of chromium. Amsterdam: Elsevier Biomedical Press, 1982:8-47.
4. Wedrychowski A, Ward WS, Schmidt WN, Hnilica LS. Chromium-induced cross-linking of nuclear proteins and DNA. J Biol Chem 1985;260:7150-5.
5. Hamilton JW, Wetterhahn KE. Chromium(VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis 1986;7: 2085-8.
6. Christie NT, Cantoni O, Evans RM, Meyn RE, Costa M. Use of mammalian DNA repair-deficient mutants to assess the effects of toxic metal compounds on DNA. Biochem Pharmacol 1984;33:1661-70
7. Cantoni O, Costa M. Analysis of the induction of alkali sensitive sites in the DNA by chromate and other agents that induce single strand breaks. Carcinogenesis 1984;5:1207-9.
8. Zhitkovich A, Voitkun V, Costa M. Glutathione and free amino acids from stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis 1995; 16:907-13.
9. Connett PH, Wetterhahn KE. In vitro reaction of the carcinogen chromate with cellular thiols and carboxylic acids. J Am Chem Soc 1985;107: 4282-88.
10. O'Brien P, Barrett J, Swanson F. Chromium(V) can be generated in the reduction of chromium(VI) by glutathione. Inorg Chim Acta 1985; 108:L19.
11. Goodgame DML, Joy AM. EPR study of the Cr(V) and radical species produced in the reduction of Cr(VI) by ascorbate. Inorg Chim Acta 1987;135:115-8.
12. Jones P, Kortenkamp A, O'Brien P, Wang G, Yang G. Evidence for the generation of hydroxyl radicals from a chromium(V) intermediate isolated from the reaction of chromate with glutathione. Arch Biochem Biophys 1991, 286:652-5.
13. Lefevbre Y, Pezerat H. Production of activated species of oxygen during the chromate(VI)-ascorbate reaction: implication in carcinogenesis. Chem Res Toxicol 1992;5:461-3.
14. O'Brien P, Kortenkamp A. Chemical models important in understanding the ways in which chromate can damage DNA. Env Health Perspect 1994,102(Suppl 3):3-10.
15. Stearns DM, Wetterhahn KE. Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem Res Toxicol 1994;7:219-30.
16. da Cruz Fresco P, Kortenkamp A. The formation of DNA cleaving species during the chromate by ascorbate. Carcinogenesis 1994;15: 1773-6.
17. Casadevall M, Kortenkamp A. The formation of both apurinic/apyrimidinic sites and single-strand breaks by chromate and glutathione arises from attack by the same single reactive species and is dependent on molecular oxygen. Carcinogenesis 1995;16:805-9.
18. Buettner GR. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals. J Biochem Biophys Methods 1988;16.27-40.
19. Dizdaroglu M. Application of capillary gas chromatography-mass spectrometry to chemical characterization of radiation-induced base damage in DNA: Implications for assessing DNA repair processes. Analyt Biochem 1985; 144:593-603.
20. Aruoma OI, Halliwell B, Gajewski E, Dizdaroglu M. Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem 1989;264:20509-12.
21. Cohen SN, Chang ACY, Hsu L. Non-chromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R factor DNA. Proc Natl Acad Sci USA 1972;69:2110-4.
22. Pierre J, Laval J. Specific nicking of DNA at apurinic sites by peptides containing aromatic residues. J Biol Chem 1981;256:10217-20.
23. Kow YW. Mechanism of action of Escherichia coli exonuclease III. Biochemistry 1989;28: 3280-7.
24. Lindahl T, Anderson A. Rate of chain breakage at apurinic sites in double stranded deoxyribo-nucleic acid. Biochemistry 1972;11:3618-23.
25. Dedon PC, Goldberg IH. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumour antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chem Res Toxicol 1992;5:311-32.
26. Hatayama T, Goldberg IH. Deoxyribonucleic acid sugar damage in the action of neocarzinostatin. Biochemistry 1980;19:5890-8.
27. Povirk LF, Steighner RJ. Oxidized apurinic/ apyrimidinic sites formed in DNA by oxidative mutagens. Mutat Res 1989,214:13-22.
28. Kortenkamp A, Ozolins Z, O'Brien P, Beyersmann D. Generation of PM2 DNA breaks in the course of reduction of chromium(VI) by glutathione. Mutat Res 1989;216:19-26.
29. Sugden KD, Burris RB, Rogers SJ. An oxygen dependence in chromium mutagenesis. Mutat Res 1990;244:239-44.
30. Kortenkamp A, Casadevall M, Faux S, Jenner A, Woodbridge N, O'Brien P. Evidence for the activation of molecular oxygen during the reduction of the carcinogen chromium(VI) by glutathione via non-Fenton pathways. 1996. Submitted to Arch Biochem Biophys.
31. Loeb LA, Preston BD. Mutagenesis by apurinic/apyrimidinic sites. Ann Rev Genet 1986; 20:201-30.
32. Stearns DM, Kennedy LJ, Courtney KD, Giangrande PH, Phieffer LS, Wetterhahn KE. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry 1995;34:910-9.